These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 17708514)

  • 21. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
    Panhard X; Mentré F
    Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimum sample size allocation to minimize cost or maximize power for the two-sample trimmed mean test.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):283-98. PubMed ID: 18157920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
    Guo JH; Chen HJ; Luh WM
    Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Nie L; Chu H; Cole SR
    Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic equivalence: fallacies and falsification.
    Garrett AD
    Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size determination for testing equality in Poisson frequency data under an AB/BA crossover trial.
    Lui KJ
    Pharm Stat; 2013; 12(2):74-81. PubMed ID: 23364859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interval estimation of the proportion ratio under multiple matching.
    Lui KJ
    Stat Med; 2005 Apr; 24(8):1275-85. PubMed ID: 15565736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size determination for matched-pair equivalence trials using rate ratio.
    Tang NS; Tang ML; Wang SF
    Biostatistics; 2007 Jul; 8(3):625-31. PubMed ID: 17071862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple formula for sample size calculation in equivalence studies.
    Zhang P
    J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On tests of rate ratio under standard inverse sampling.
    Tang ML; Liao YJ; Ng HK
    Comput Methods Programs Biomed; 2008 Mar; 89(3):261-8. PubMed ID: 18164512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A note on sample size calculation for mean comparisons based on noncentral t-statistics.
    Chow SC; Shao J; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):441-56. PubMed ID: 12477068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance in clinical trials: impact on design, analysis and interpretation.
    Pledger GW
    Epilepsy Res Suppl; 1988; 1():125-33. PubMed ID: 3072187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of testing times and critical values in sequential equivalence testing.
    Müller HH; Schäfer H
    Stat Med; 1999 Jul; 18(14):1769-88; discussion 1789. PubMed ID: 10407247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approximate approach to sampling size determination for the equivalence hypothesis.
    Hsieh CY; Liu JP
    J Biopharm Stat; 2013 May; 23(3):526-38. PubMed ID: 23611193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size adjustments for varying cluster sizes in cluster randomized trials with binary outcomes analyzed with second-order PQL mixed logistic regression.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2010 Jun; 29(14):1488-501. PubMed ID: 20101669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.